India has the chance to lead in CRISPR technology by driving ethical gene editing innovations in healthcare, agriculture, and ...
Explore why Recursion Pharmaceuticals' AI-driven drug discovery faces challenges in revenue growth, governance, and investor ...
Market was valued at USD 472.77 Million in 2024 and is expected to reach USD 728.10 Million by 2030, growing at a CAGR of 7.42% during the forecast period. The market is being driven by the increasing ...
The Vietnam Pharmaceuticals Market was valued at USD 7.60 billion in 2024 and is projected to reach USD 12.12 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.96% during the ...